$280.00
$0.00 (0.00%)
End-of-day quote: 05/18/2024
ASX:CSL
CSL Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NOVO B | Novo Nordisk A/S | CPSE | Outperform | kr903.30 | kr696.07 | 0.00% | 14 | kr4.01T |
| JNJ | Johnson & Johnson | NYSE | Outperform | $154.64 | $174.55 | 0.00% | 3 | $372.17B |
| MRK | Merck | NYSE | Outperform | $131.19 | $130.51 | 0.00% | 11 | $332.28B |
| AZN | AstraZeneca PLC | LSE | Outperform | £121.10 | £165.99 | 0.00% | 16 | £187.73B |
| NOVN | Novartis | SWX | Hold | CHF93.37 | CHF105.00 | 0.00% | 9 | CHF190.51B |
| ABT | Abbott Laboratories | NYSE | Outperform | $104.09 | $118.92 | 0.00% | 7 | $181.08B |
| PFE | Pfizer | NYSE | Outperform | $28.64 | $32.87 | 0.00% | 6 | $162.29B |
| SAN | Sanofi | ENXTPA | Outperform | 89.17€ | 102.80€ | 0.00% | 9 | 111.47€B |
| VRTX | Vertex Pharmaceuticals Inc | NASDAQ | Outperform | $445.21 | $457.59 | 0.00% | 11 | $114.89B |
| GSK | GSK | LSE | Outperform | £17.75 | £17.30 | 0.00% | 12 | £72.39B |
| GILD | Gilead Sciences Inc | NASDAQ | Outperform | $67.72 | $87.82 | 0.00% | 14 | $84.36B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.13k | ¥4.74k | 0.00% | 0 | ¥6.48T |
| BIIB | Biogen | NasdaqGS | Outperform | $230.57 | $299.62 | 0.00% | 13 | $33.57B |
| BAYN | Bayer | XTRA | Hold | 28.58€ | 45.15€ | 0.00% | 4 | 28.08€B |
| UCB | UCB | ENXTBR | Outperform | 124.70€ | 102.66€ | 0.00% | 7 | 23.66€B |
| BAX | Baxter International Inc | NYSE | Hold | $35.25 | $44.86 | 0.00% | 5 | $17.96B |
| 4503 | Astellas Pharma | TSE | Outperform | ¥1.49k | ¥2.64k | 0.00% | 0 | ¥2.67T |
| SOBI | Swedish Orphan Biovitrum AB (p... | OM | Outperform | kr277.00 | kr293.00 | 0.00% | 6 | kr96.39B |
| 600161 | Beijing Tiantan Biological Pro... | SHSE | Outperform | ¥28.70 | ¥31.28 | 0.00% | 1 | ¥50.09B |
| 002252 | Shanghai RAAS Blood Products | SZSE | Outperform | ¥7.37 | ¥9.08 | 0.00% | 0 | ¥49.67B |
| GRF | Grifols | BME | Outperform | 9.89€ | 18.48€ | 0.00% | 3 | 5.85€B |
| 002007 | Hualan Biological Engineering | SZSE | Outperform | ¥19.65 | ¥25.89 | 0.00% | 0 | ¥36.17B |
| ITRI | Itron | NasdaqGS | Outperform | $109.05 | $77.33 | 0.00% | 0 | $4.98B |
| BIOCON | Biocon | NSEI | Hold | Rp305.85 | Rp270.86 | 0.00% | 14 | Rp365.06B |
| PFIZER | Pfizer | NSEI | Outperform | Rp4.40k | Rp4.53k | 0.00% | 3 | Rp201.32B |
| ADMA | ADMA Biologics | NasdaqGM | Buy | $9.21 | $6.00 | 0.00% | 0 | $2.04B |
| BIO3 | Biotest | XTRA | Hold | 27.60€ | 37.00€ | 0.00% | 0 | 1.38€B |
| BCRX | BioCryst Pharmaceuticals | NasdaqGS | Outperform | $6.28 | $14.09 | 0.00% | 2 | $1.09B |
| PHARM | Pharming Group N.V. | ENXTAM | Buy | 0.85€ | 1.85€ | 0.00% | 2 | 591.95€M |
| NVAX | Novavax | NasdaqGS | Outperform | $13.01 | $23.25 | 0.00% | 4 | $623.13M |
| 4105 | TTY Biopharm Company | TPEX | Hold | NT$77.50 | NT$86.00 | 0.00% | 0 | NT$19.22B |
| KALV | KalVista Pharmaceuticals | NasdaqGM | Buy | $11.92 | $20.80 | 0.00% | 0 | $478.84M |
| 4142 | Adimmune | TWSE | - | NT$31.05 | NT$55.00 | 0.00% | 0 | NT$14.08B |
| KENDR | Kendrion N.V. | ENXTAM | Outperform | 12.92€ | 15.17€ | 0.00% | 2 | 202.56€M |
| ABEO | Abeona Therapeutics | NasdaqCM | Buy | $4.40 | $21.25 | 0.00% | 2 | $114.89M |
| 6833 | Sinco Pharmaceuticals Holdings | SEHK | - | HK$0.24 | HK$0.46 | 0.00% | 0 | HK$528.55M |
| LUPA3 | Lupatech | BOVESPA | - | R$1.63 | R$1.90k | 0.00% | 0 | R$67.78M |
